Cancer, unfortunately, is the scourge of our age. However, the advancement of technology and the development of artificial intelligence will help fight this disease. Dell and the University of Limerick (UL) in Ireland have teamed up to bring hope to cancer patients. They will use artificial intelligence to advance cancer research. They plan to diagnose and prevent cancer earlier, thanks to artificial intelligence. Additionally, with the inclusion of artificial intelligence in cancer research, doctors will be able to apply a more personalized treatment based on the characteristics of the tumor.
Artificial intelligence will add a whole new dimension to cancer research!
Artificial intelligence will shed light on cancer research. Technology giant Dell and the University of Limerick (UL) in Ireland will act jointly to fight cancer. This collaboration will positively impact the treatment process of B-cell lymphoma patients. The research, supported by artificial intelligence, is carried out at UL’s Digital Cancer Research Centre. As a result of these studies, faster diagnosis will be possible. It is also aimed to manage the treatment process more efficiently.
Dell has developed a new artificial intelligence platform to achieve this. The company’s latest storage arrays and PowerEdge servers also support this AI platform. In this way, the artificial intelligence platform has become a part of the multi-cloud ecosystem. It can also produce digital twins of patients. In this way, researchers will observe the microenvironment of the tumor. It will also model the role cancer cells can play in spreading throughout the body and central nervous system.
Robots descending into the lungs: Significant progress has been made in cancer treatment!
An important development has been made for cancer, one of the biggest scourges of humanity. Here are the robot tentacles that descend into the lungs!
Technology will facilitate researchers’ work in many ways. It will accelerate biomarker testing for cancer. In this way, with early diagnosis, treatment will begin before cancer cells spread to other tissues. He or she will also provide more information about appropriate treatments. Thus, doctors will be able to develop personalized treatments according to the individual’s tumor characteristics.
UL Professor of Molecular Pathology and Director Paul Murray; “Through our partnership with the Dell Technologies team, we will be able to advance our knowledge of how cells go wrong during cancer development. “We will be able to find new ways to diagnose and treat cancer patients.” said.